 |
市场调查报告书
商品编码
1567232
慢性病管理市场：按疾病类型、按服务类型、按交付方式、按最终用户、按地区Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography |
||||||
预计2024年全球慢性病管理市场规模为57.1亿美元，2031年将达138亿美元，2024年至2031年复合年增长率为13.4%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 57.1亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 13.40% | 2031年价值预测 | 138亿美元 |
糖尿病、癌症、心血管疾病 (CVD)、慢性阻塞性肺病(COPD) 和气喘等慢性疾病是需要持续医疗照护并限制日常生活的长期健康状况。其中大多数可以透过改变生活方式来预防，例如避免吸烟和保持健康的体重。然而，繁忙的日程和紧张的生活使这些症状难以控制。这增加了对更好的慢性病管理技术的需求。远端患者监护方面的各种技术进步以及政府改善医疗基础设施的努力可能会在不久的将来推动市场成长。
市场动态：
全球慢性病管理市场的成长是由患有多种慢性病的老年人口增加、肥胖和饮食习惯改变导致的糖尿病和心血管疾病等与文明病率增加以及早期发现推动的这是由于人们对医疗保健和疾病管理的好处的认识不断提高、数位医疗解决方案的技术进步以及各国政府和私营组织为遏制医疗成本上涨而做出的努力等因素推动的。然而，对资料隐私的担忧、实施远端监控设备和服务的高成本以及开发中国家缺乏熟练的医疗保健专业人员可能会阻碍更快的采用。开拓的管理多种疾病的综合平台、扩大人工智慧和可穿戴技术的作用以及日益关注个性化护理，为市场参与者提供了利润丰厚的成长机会。
本研究的主要特点
该报告对全球慢性病管理市场进行了详细分析，以2023年为基准年估计了预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球慢性病管理市场的主要企业进行了分析。
本研究涵盖的主要企业包括 IBM、Cerner Corporation、Epic Systems、McKesson Corporation、Athenahealth、Healthagen、Allscripts、Optum（UnitedHealth Group 的一部分）、Conifer Health Solutions、NXGN Management、Phytel、I2I Population Health 和 Includes Healthwise。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球慢性病管理市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球慢性病管理市场的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球慢性病管理市场－冠状病毒（COVID-19）大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球慢性病管理市场，依疾病类型，2019-2031（十亿美元）
- 心血管疾病
- 糖尿病
- 呼吸系统疾病
- 癌症
- 慢性肾臟病
- 其他的
第六章 全球慢性病管理市场，依服务类型，2019-2031 年（十亿美元）
- 疾病管理计划
- 远端患者监护
- 远端医疗服务
- 其他的
第七章 全球慢性病管理市场，以交付方式，2019-2031 年（十亿美元）
- 本地
- 基于网路的
- 云端基础
第 8 章 全球慢性病管理市场，依最终用户划分，2019-2031 年（十亿美元）
- 医院
- 专科诊所
- 家庭护理设置
- 其他的
第九章全球慢性病管理市场，按地区，2019-2031，（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第10章竞争格局
- 公司简介
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna（a CVS Health company）
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
第十一章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十二章参考文献与调查方法
- 参考
- 调查方法
Global chronic disease management market is estimated to be valued at USD 5.71 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 5.71 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 13.40% | 2031 Value Projection: | US$ 13.80 Bn |
Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.
Market Dynamics:
Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.
Key features of the study:
This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market
Detailed Segmentation-
- Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Cancer
- Chronic Kidney Disease
- Others (Arthritis, etc.)
- Service Type Insights (Revenue, USD Bn, 2019 - 2031)
- Disease Management Programs
- Remote Patient Monitoring
- Telehealth Services
- Others (Diagnostic Services, etc.)
- Delivery Mode Insights (Revenue, USD Bn, 2019 - 2031)
- On-premise
- Web-based
- Cloud-based
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Specialty Clinics
- Home Care Settings
- Others (Pharmaceutical Companies, etc.)
- Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna (a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Service Type
- Market Snapshot, By Delivery Mode
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Chronic Disease Management Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Chronic Disease Management Market, By Disease Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic Kidney Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Chronic Disease Management Market, By Service Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Disease Management Programs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Remote Patient Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Telehealth Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Chronic Disease Management Market, By Delivery Mode, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- On-premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Web-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cloud-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Chronic Disease Management Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Home Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Chronic Disease Management Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- UnitedHealth Group
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna (a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
- UnitedHealth Group
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
